The global cannabis markets have been experiencing a rapid growth rate in the last few years and they are projected to rise even faster and further in the coming years. Sometimes, though, it's hard to get the experts agree to the numbers. But they do all agree that revenues will continue to rise. For example, a report from Green Entrepreneur forecasts $40 billion sales in the global cannabis markets by 2024. Another report from Grandview Research projected that the global legal marijuana market size is expected to reach $66.3 billion by the end of 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 23.9% during the forecast period. Increasing legalization and use of marijuana in medical as well as recreational applications is expected to promote the growth... and yet another report from Mordor Intelligence stated that the cannabis market was valued at USD $14.5 billion in 2018, and it is projected to reach $89.1 billion by 2024, with a CAGR of 37%. Active Companies from around the market this week include: Player's Network, Inc. (OTC: PNTV), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), The Supreme Cannabis Company Inc. (OTCQX: SPRWF) (TSX: FIRE), Isodiol International Inc. (OTCQB: ISOLF) (CSE: ISOL).

MoCanna, which will operate the soon-to-open byMinistry flagship location in Toronto, is pleased to announce that the world's biggest cannabis company Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) will lead its Series A fundraising with a $2 million (CAD) investment for a 7.8 per cent stake of the company. Cannaglobal, a premium cannabis CPG brand company, will remain MoCanna's largest shareholder with 24.2 per cent of shares held. This investment follows a very strong initial seed round raising $4 million (CAD), which closed in December 2018. MoCanna expects its Series A round to close September 30, 2019.

SMITHS FALLS, ON , Aug. 20, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED ), (NYSE: CGC ) ("Canopy Growth" or the "Company") is pleased to announce that it has received a licence from Health Canada for its KeyLeaf Life Sciences ("KeyLeaf") facility in Saskatoon, Saskatchewan . Including the Smiths Falls site and the recently licensed BC Tweed extraction site, Canopy Growth now operates three significant extraction assets to support the throughput required for large scale value-add product development.